Laddar...

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

BACKGROUND: Sodium glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of heart failure and new data show they can prevent atrial fibrillation (AF). We examined the association between SGLT2i and AF in the Food and Drug Administration adverse event reporting system (FAERS). METHODS: We mined...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cardiovasc Diabetol
Huvudupphovsmän: Bonora, Benedetta Maria, Raschi, Emanuel, Avogaro, Angelo, Fadini, Gian Paolo
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879696/
https://ncbi.nlm.nih.gov/pubmed/33573667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-021-01243-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!